Abstract
HEPATOCELLULAR carcinoma (HCC) is a prevalent cancer in sub-Saharan Africa and eastern Asia1. Hepatitis B virus and aflatoxins are risk factors for HCC2, but the molecular mechanism of human hepatocellular carcinogenesis is largely unknown3. Abnormalities in the structure and expression of the tumour-suppressor gene p53 are frequent in HCC cell lines4, and allelic losses from chromosome 17p have been found in HCCs from China5 and Japan6. Here we report on allelic deletions from chromosome 17p and mutations of the p53 gene found in 50% of primary HCCs from southern Africa. Four of five mutations detected were G → T substitutions, with clustering at codon 249. This mutation specificity could reflect exposure to a specific carcinogen, one candidate being aflatoxin B1 (ref. 7), a food contaminant in Africa8, which is both a mutagen that induces G to T substitution9 and a liver-specific carcinogen10.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Parkin, D. M., Laara, E. & Muir, C. S. Int. J. Cancer 41, 184–197 (1988).
Bosch, F. X. & Munoz, N. in Liver Cell Carcinoma (eds Bannasch, P., Keppler, D. & Weber, G.) 3–14 (Kluwer Academic, Dordrecht, 1989).
Harris, C. C. Cancer Cells 2, 146–148 (1990).
Bressac, B. et al. Proc. natn. Acad. Sci. U.S.A. 87, 1973–1977 (1990).
Slagle, B. L., Zhou, Y.-Z. & Butel, J. S. Cancer Res. 51, 49–54 (1991).
Fujimori, M. et al. Cancer Res. 51, 89–93 (1991).
Ames, B. N., Durston, W. E., Yamasaki, E. & Lee, F. D. Proc. natn. Acad. Sci. U.S.A. 70, 2281–2285 (1973).
Van Rensburg, S. J. et al. Brit. J. Cancer 51, 713–726 (1985).
Foster, P. L., Eisenstadt, E. & Miller, J. H. Proc. natn. Acad. Sci. U.S.A. 80, 2695–2698 (1983).
Newberne, P. M. & Butler, W. H. Cancer Res. 29, 236–250 (1969).
Nakamura, Y. et al. Nucleic Acids Res. 16, 5707 (1988).
Masharani, U., Wolf, D. & Frossard, P. M. Nucleic Acids Res. 16, 7757 (1988).
Baker, S. J. et al. Science 244, 217–221 (1989).
Nigro, J. M. et al. Nature 342, 705–708 (1989).
Chiba, I. et al. Oncogene 5, 1603–1610 (1990).
Hsu, I. C. et al. Nature 350, 427–428 (1991).
Marshall, C. J. Cell 64, 313–326 (1991).
Dejean, A., Bougueleret, L., Grzeschik, K-H. & Tiollais, P. Nature 322, 70–73 (1986).
Wang, J., Chenivesse, X., Henglein, B. & Brechot, C. Nature 343, 555–557 (1990).
Yeh, F.-S. et al. Cancer Res. 49, 2506–2509 (1989).
Muench, K. F., Misra, R. P. & Humayun, M. Z. Proc. natn. Acad. Sci. U.S.A. 80, 6–10 (1983).
Saiki, R. K. et al. Science 239, 487–491 (1988).
Malkin, D. et al. Science 250, 1233–1238 (1990).
Frohlich, M. et al. Molec. cell. Biol. 10, 3216–3223 (1990).
Alexander, J. J., Bey, E., Geddes, E. & Lacetsas, G. S. Afr. Med. J. 50, 2124–2128 (1976).
Yang, S. S. et al. Cancer Res. 50, 5658s–5667s (1990).
Aden, D. P., Fogel, A. Plotkin, S. Damjanov, I. & Knowles, B. Nature 282, 615–616 (1979).
Nakabayashi, H. et al. Jpn J. Cancer Res/(GANN) 75, 151–158 (1984).
He, L. et al. In Vitro 20, 493–503 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bressac, B., Kew, M., Wands, J. et al. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350, 429–431 (1991). https://doi.org/10.1038/350429a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/350429a0
This article is cited by
-
Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers
Cancer and Metastasis Reviews (2023)
-
Green tea-derived theabrownin induces cellular senescence and apoptosis of hepatocellular carcinoma through p53 signaling activation and bypassed JNK signaling suppression
Cancer Cell International (2022)
-
Enzymatic degradation is an effective means to reduce aflatoxin contamination in maize
BMC Biotechnology (2021)
-
Use of proteomics to identify mechanisms of hepatocellular carcinoma with the CYP2D6*10 polymorphism and identification of ANGPTL6 as a new diagnostic and prognostic biomarker
Journal of Translational Medicine (2021)
-
Hepatocellular carcinoma
Nature Reviews Disease Primers (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.